...
首页> 外文期刊>American Journal of Pathology: Official Publication of the American Association of Pathologists >Lipopolysaccharide-Induced Increase in Intestinal Epithelial Tight Permeability Is Mediated by Toll-Like Receptor 4/Myeloid Differentiation Primary Response 88 (MyD88) Activation of Myosin Light Chain Kinase Expression
【24h】

Lipopolysaccharide-Induced Increase in Intestinal Epithelial Tight Permeability Is Mediated by Toll-Like Receptor 4/Myeloid Differentiation Primary Response 88 (MyD88) Activation of Myosin Light Chain Kinase Expression

机译:脂多糖诱导的肠上皮紧密渗透性的增加通过Toll样受体4 /髓样分化初级反应88(MyD88)活化肌肌瘤轻链激酶表达

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Lipopolysaccharides (LPSs) are a major component of the Gram-negative bacterial cell wall and play an important role in mediating intestinal inflammatory responses in inflammatory bowel disease. Although recent studies suggested that physiologically relevant concentrations of LPS (0 to 1 ng/mL) cause an increase in intestinal epithelial tight junction (TJ) permeability, the mechanisms that mediate an LPS-induced increase in intestinal TJ permeability remain unclear. Herein, we show that myosin Light chain kinase (MLCK) plays a central role in the LPS-induced increase in TJ permeability. Filter-grown Caco-2 intestinal epithelial monolayers and C57BL/6 mice were used as an in vitro and in vivo intestinal epithelial model system, respectively. LPS caused a dose- and time-dependent increase in MLCK expression and kinase activity in Caco-2 monolayers. The pharmacoLogic MLCK inhibition and siRNA-induced knock-down of MLCK inhibited the LPS-induced increase in Caco-2 TJ permeability. The LPS increase in TJ permeability was mediated by toll-like receptor 4 (TLR-4)/MyD88 signal-transduction pathway up-regulation of MLCK expression. The LPS-induced increase in mouse intestinal permeability also required an increase in MLCK expression. The LPS-induced increase in intestinal permeability was inhibited in MLCK-/- and TLR-4(-/-) mice. These data show, for the first time, that the LPS-induced increase in intestinal permeability was mediated by TLR-4/MyD88 signal-transduction pathway up-regulation of MLCK. Therapeutic targeting of these pathways can prevent an LPS-induced increase in intestinal permeability.
机译:脂多糖(LPSS)是革兰氏阴性细菌细胞壁的主要成分,并在介导炎症肠疾病中介导肠炎炎症反应发挥重要作用。尽管最近的研究表明,生理相关的LPS(0至1ng / mL)浓度导致肠上皮紧密接头(TJ)渗透性的增加,介导LPS诱导的肠TJ渗透率的机制仍不清楚。在此,我们表明肌球蛋白轻链激酶(MLCK)在LPS诱导的TJ渗透性增加中起着核心作用。过滤生长的Caco-2肠上皮单层和C57BL / 6小鼠分别用作体外和体内肠上皮模型系统。 LPS引起CaCO-2单层中的MLCK表达和激酶活性的剂量和时间依赖性增加。 MLCK的药理学MLCK抑制和siRNA诱导的敲低抑制了LPS诱导的CaCO-2 TJ渗透性的增加。 TJ渗透率的LPS增加是通过Toll样受体4(TLR-4)/ MyD88信号转导通路的MLCK表达的上调介导的。小鼠肠道渗透率的LPS诱导的增加也需要增加MLCK表达。在MLCK - / - 和TLR-4( - / - )小鼠中抑制了LPS诱导的肠道渗透性的增加。这些数据显示,首次显示LPS诱导的肠道渗透性的增加通过TLR-4 / MYD88信号转导通路介导的MLCK。这些途径的治疗靶向可以防止LPS诱导的肠道渗透性增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号